U.S. federal trademark · Serial No. 98851591
Research and preclinical drug development in the field of cell reprogramming, gene editing technology, specimen procurement, stem cell banking, cell differentiation, cell separation, stem cell generation, gene editing, 2D or 3D model generation, 2D or 3D model drug screening, cell characterization, assay-ready and cryopreserved cell products
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.